White paperThe Enterprise Framework for Compliant, Scalable AI
Download now
Continuous complianceDataRegulations

Medical Device Company Updates 450 QMS SOPs in time for EU MDR

Case study on Medical Device Company Updates 450 QMS SOPs in time for EU MDR.

Client profile: Large medical device company restructuring into a centralized corporate quality organization, with roughly $1B of EU revenue dependent on EU MDR compliance.

Medical Device Company Updates 450 QMS SOPs in time for EU MDR graphic

Executive takeaway

USDM assessed and updated 450 QMS SOPs for EU MDR compliance in a single month, delivering the equivalent of one man-year of technical writing and protecting approximately $1B of EU revenue.

QMS SOPs Updated

450

QMS SOPs assessed, redlined, and brought into EU MDR compliance — up from an initial scope of 300 documents.

Time to Complete

1 Month

USDM delivered the equivalent of one man-year of technical writing within a single month to hit the EU MDR deadline.

Technical Writers Deployed

9

Nine experienced technical writers hired and deployed under a project manager and an EU MDR expert consultant to achieve the customer objective.

Before USDM

  • Director of Quality Programs lacked the resources to review and update QMS documents before the critical EU MDR deadline.
  • Two siloed divisions and separate QMS elements with no holistic QMS owner to coordinate the effort.
  • Roughly $1B of EU revenue exposed to EU MDR non-compliance risk.

After USDM

  • 450 QMS SOPs assessed, redlined, and made EU MDR compliant.
  • Two siloed divisions brought together to ensure all required QMS documents were updated in time.
  • EU MDR deadline met, protecting approximately $1B of EU revenue.

Challenge

A large medical device company faced a hard EU MDR deadline with roughly $1B of EU revenue on the line. Its Quality Management System SOPs had to be assessed and updated for compliance, but the organization wasn't structured to move fast.

  • The Director of Quality Programs lacked the resources needed to review and update QMS documents in time for the critical EU MDR deadline.
  • There was no holistic QMS owner who could break down the company and QMS element silos.
  • The customer was simultaneously restructuring into a central corporate quality structure.
  • An initial scope of roughly 300 documents was projected for review at the onset of the project.

Without focused execution capacity, the company risked missing the deadline and exposing its EU revenue — a clear case for a disciplined, continuous compliance approach to quality documentation.

Approach

Using a managed staffing delivery model, USDM assigned a team of subject matter experts to the project: a project manager, an EU MDR expert consultant, and nine technical writers. USDM first assessed the customer's QMS SOPs against EU MDR requirements, then presented its observations and findings. Based on that assessment, the customer hired USDM to perform all SOP updates.

A 4-tier process to move documents at scale

To keep hundreds of documents moving in parallel without losing control, USDM developed a four-tier process:

  • Load — intake and stage each SOP for review.
  • Review — evaluate each document against EU MDR requirements.
  • Redline — author the required changes while preserving data integrity across the document set.
  • Approve — route updates through quality approval.

Daily status meetings, led by USDM, kept the team on track and surfaced blockers early. As work progressed, the scope grew from the projected 300 documents to 450. USDM also brought together two siloed divisions of the customer's organization so that all required QMS documents were updated in time for EU MDR — a coordination challenge that internal teams had struggled with. This kind of cross-functional ownership is the same discipline that underpins effective 21 CFR Part 11 compliance programs.

Results

By deploying nine experienced technical writers, USDM delivered the equivalent of one man-year of technical writing of SOPs within one month — meeting the EU MDR deadline and protecting approximately $1B of EU revenue.

  • 450 QMS SOPs made EU MDR compliant with the help of USDM.
  • 9 technical writers hired, deployed, and aligned to achieve the customer objective.
  • 1 month to complete the project.

As the customer put it: "USDM got more done in a month than we did in the last year."

When a regulatory deadline meets a resource gap, the right team and a repeatable process turn risk into a completed, audit-ready quality system. Ready to protect your own deadlines? Explore USDM's continuous compliance services or contact us to talk through your QMS and EU MDR readiness.

EU MDR & Quality Readiness

Hit your next quality deadline with confidence

Facing a QMS overhaul or a hard regulatory deadline? USDM's continuous compliance teams assess, redline, and update your SOPs at scale — keeping your quality system audit-ready and your revenue protected.

Talk to a Compliance Expert

Go deeper

Related guidance

Blogs, webinars, and white papers on the capabilities behind this outcome.

Webinar

Work Faster and Smarter in Biotech Quality Management

Watch this on-demand webinar to see how Box, ComplianceQuest, and USDM Life Sciences bundle quality management so biotechs cut stand-up times, control costs, and run a best-of-breed compliance stack.

Read
Webinar

An Update on the FDA’s UDI and GUDID Compliance Requirements

On-demand webinar with Jay Crowley on the FDA’s tightening UDI and GUDID requirements — closing Legacy Identifier gaps, UDI in routine inspections and import screening, and how labelers can align GUDID data across FDA systems before enforcement reaches them.

Read
Blog

ETM.AI: The AI-Enabled Digital Enterprise Trace Matrix

ETM.AI from USDM and Oracle turns the Enterprise Trace Matrix into a digital, AI-powered GxP compliance fabric — embedded in the flow of work for audit readiness.

Read
Blog

UDI Data Quality Lessons for Medical Device Supply Chain Resilience

UDI data quality, GUDID maintenance, and global device traceability help medical device teams improve supply chain visibility and inspection readiness.

Read
Blog

Q&A: EU MDR Date of Application Readiness

Expert answers to the most-asked EU MDR Date of Application questions—EUDAMED registration, SRNs, legacy device transitions, PSURs, UDI, and ISO 13485:2016—from USDM's medical device webinar with Jay Crowley.

Read
Blog

UDI and FDA’s New QMSR Inspection Process

How the FDA's new QMSR inspection process and UDI requirements affect medical device companies — what changed, what to prepare for, and how to align quality management systems for the new regulatory framework.

Read

Start here

Put AI to work in life sciences — with the right guardrails underneath.

Start with a structured AI Readiness Assessment: fixed-fee, executive-ready, and built to surface the highest-value workflows first.

Start here

Talk to USDM

Tell us what workflow or outcome you want to improve and we'll map the right AI, governance, and delivery path.

By submitting this form, you agree to USDM’s Privacy Policy and consent to receive communications from USDM. You can unsubscribe at any time using the link in our emails.